At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.
The PPMI study is looking for biomarkers for Parkinson’s disease, which would help identify those at risk and track the progression of the disease.
UAB O’Neal Comprehensive Cancer Center, Morehouse School of Medicine and Tuskegee University collectively receive $18 million U54 grant from the National Cancer Institute.
After years of researching the SON gene, Erin Eun-Young Ahn, Ph.D., may have found the cause behind an extremely rare disease.
Recent studies have shown that formal exercise training can help boost memory, and memory deficit is relatively common in people with epilepsy.
COERE awarded $500,000 to provide funds for research supplements to early-career physician-scientists whose research has been impacted by COVID-19.
Basic and translational research in this field aims to repair heart injury and prevent the heart failure that often follows a heart attack.
Nearly 100,000 people in the United States have AE-IPF, and approximately 30,000 to 40,000 new cases are found each year.
The study concluded that participants were hesitant to receive the COVID-19 vaccine due to mistrust, fear and lack of information.
The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.
The Hugh Kaul Precision Medicine Institute will help build the interface of the Biomedical Data Translator, a “virtual brain” that will host all biomedical data in the world.
NIH selects UAB and UA as research sites for a longitudinal study on child development since pregnancy.
The 10-week trial will include meals provided by study investigators.
Young cancer survivors are at higher risk of developing subsequent HPV-related cancers than the general population, but less likely to receive the HPV vaccine. Findings from the first clinical trial of its kind support making HPV vaccination a routine part of oncologic care for all young cancer survivors, researchers say.
Release of TT-10 from nanoparticles improved heart function after a heart attack, accompanied by increased cardiomyocyte proliferation and smaller infarct size.
